HomeAI · summaries
Storia in 5 fonti
GSK CEO targets $2.5B in cost savings from mature products, procurement, supply chain
About half a year into his tenure as GSK’s CEO, Luke Miels is launch | About half a year into his tenure as GSK’s CEO, Luke Miels is launching a three-year restructuring designed to generate $2.5 billion in annual cost savings by 2029. The cost reductions will mainly be pulled from three levers, Miels explained on a call with reporters.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
GSK prepares for patent cliff with $2.5B cost-cutting plan
The pharma hasn’t yet revealed what kind of job cuts might be involved in the plan, which will help it absorb the coming loss of patents important to its HIV drug franchise.
- ·
cityam.com
Sweeping job cuts at GSK to fund £400m Cambridge campus
GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge in a move aimed a bolstering its pipeline.
